Similar Posts
The Verdict Is In—Price Gouging Harms People With Gout
The patient arrived in my clinic, their right big toe the color of a spring strawberry. The lightest touch caused exquisite pain. Fortunately, I was able to prescribe a pill (an ancient medicine, actually) and the patient was better by the next day.
Too bad that simple treatment is becoming unaffordable, through a maddening combination of greed and regulatory failure.
Medicare Savings Might Be Costing Us: Here’s Why
Could ACOs be costing us money?
Science Isn’t Meant To Be Followed
Science cannot lead us out of this pandemic. Whatever paths we take to navigate COVID-19 need to be chosen through political processes. The true role of science is to illuminate these pathways, guiding our policy choices by showing us what’s at stake.
Here’s Why Pharmaceutical Companies Raise Their Prices So Much
Yes, I’ve ranted about healthcare prices before. On more than one occasion. But I have a new rant for you. It’s not about the high price of new drugs It’s not about a couple pharmo-bro CEOs hiking prices of generic medications by 4 or 5,000% It’s about brand name drugs already on the market, that,…
Drugs Are Outrageously Expensive—Canada Found A Way To Fight Back
Latuda is a drug to treat schizophrenia. It costs about $4,000 per month in the U.S. In Canada, the price is closer to $500.
Ibrance, a breast cancer drug, costs $10,000 more per month in the U.S. than in Canada.
Why these enormous price differences?
